Trial · NCT07891806
REM Sleep Disruption and Its Potential Uses in Depression Management
NCT07891806, Not applicable, Completed, WAKEZ HEALTH TECH ECOSYSTEM SRL
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. REM Sleep Disruption and Its Potential Uses in Depression Management. Trials, record NCT07891806. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891806
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- REM Sleep Disruption and Its Potential Uses in Depression Management
- NCT number
- NCT07891806
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 208 participants, actual
- Lead sponsor
- WAKEZ HEALTH TECH ECOSYSTEM SRL
- Conditions
- Depression / Major Depressive Disorder, Depressed Mood
- Interventions
- REM-Contingent Smartwatch Haptic Stimulation, Smartwatch Sleep Monitoring and Smart Alarm
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Final Montgomery-Åsberg Depression Rating Scale (MADRS) Score | Baseline and final post-intervention assessment, within 40 days after completion of the intervention. | Clinician-rated depressive symptom severity measured using the Montgomery-Åsberg Depression Rating Scale (MADRS). The primary analysis compared final MADRS scores between the experimental and control groups using analysis of covariance (ANCOVA), adjusted for baseline MADRS score. Lower MADRS scores indicate lower depressive symptom severity. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07891806
GET https://conductscience.org/api/trials/v1/NCT07891806/registered